AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. It is ranked sixth on the list of largest biomedical companies by revenue. In 2023, the company's seat in Forbes Global 2000 was 74. The company's primary product is Humira (adalimumab) ($14 billion in 2023 revenues, 27 percent of total), administered via injection.
- Hızlı yanıt
- Arama sonuçları
- AbbVie pharmaceuticals combines advanced science with expertise to make strides in drug and treatment discovery, making a remarkable impact on people's...
- Skip to main content. Türkiye • AbbVie Türkiye. ... AbbVie Türkiye son olarak Türkiye Spastik Çocuklar Vakfı'nın (TSÇV) deprem bölgesinde yaşayan engelli ve...
Telefon
Bulunamadı: inc - AbbVie Inc. Overview Drug Manufacturers - General / Healthcare. ... The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
- AbbVie Inc (ABBV). ... AbbVie içindeki en son hareketleri izleyin. Hisse senedi fiyat tablosunu aşağıda bulabilirsiniz.
- American pharmaceutical company. AbbVie Inc. ... AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois.
- 36K Followers, 48 Following, 604 Posts - AbbVie (@abbvie) on Instagram: "A biopharma focused on delivering medicines & solutions that make a real impact...Bulunamadı: inc
- AbbVie Inc. is a publicly-traded biopharmaceutical company headquartered in North Chicago, Illinois. The company was formed in 2013 after Abbott...
- AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world.Bulunamadı: inc
- AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture and sale of a range...
- AbbVie Inc stock (ABBV.xnys) is listed on the New York Stock Exchange (NYSE) and had a $45.80B (USD) market capitalisation as of January 2022.